Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aadi Biosciences Inc (AADI)

Aadi Biosciences Inc (AADI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aadi Biosciences Inc 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 USA

aadibio.com Employees: 89 P: 424-473-8055

Description:

Aadi Bioscience Inc. is a clinical-stage biopharmaceutical company. It focuses on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Aadi Bioscience Inc., formerly known as Aerpio Pharmaceuticals Inc., is based in LOS ANGELES.

Key Statistics

Overview:

Market Capitalization, $K 47,635
Enterprise Value, $K -15,255
Shares Outstanding, K 24,554
Annual Sales, $ 24,350 K
Annual Net Income, $ -65,770 K
Last Quarter Sales, $ 6,180 K
Last Quarter Net Income, $ -14,580 K
EBIT, $ -70,650 K
EBITDA, $ -73,620 K
60-Month Beta 0.70
% of Insider Shareholders 37.30%
% of Institutional Shareholders 52.08%
Float, K 15,395
% Float 62.70%
Short Volume Ratio 0.57

Growth:

1-Year Return -57.37%
3-Year Return -92.53%
5-Year Return -73.74%
5-Year Revenue Growth 20.78%
5-Year Earnings Growth 47.53%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 08/07/24
Next Earnings Date 11/13/24
Earnings Per Share ttm -2.42
EPS Growth vs. Prev Qtr 20.59%
EPS Growth vs. Prev Year 19.40%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/27/21

AADI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -66.67%
Return-on-Assets % -54.00%
Profit Margin % -270.10%
Debt/Equity 0.00
Price/Sales 1.94
Price/Cash Flow N/A
Price/Book 0.60
Book Value/Share 3.21
Interest Coverage -284.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar